Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer [Phase 2]
A Phase 2 trial evaluating a rebeccamycin analogue in patients with refractory stage III/IV ovarian epithelial cancer has been terminated. T…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 study of arzoxifene hydrochloride in women with metastatic refractory ovarian cancer or primary peritoneal cancer; the trial has com…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy [Phase 3]
This update reports on a Phase 3 trial of amifostine in patients with ovarian epithelial cancer undergoing chemotherapy; the trial status is…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating octreotide as palliation for cancer-related bowel obstruction that cannot be removed by surgery; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine [NA]
A completed clinical trial investigating complementary and alternative medicine approaches in ovarian, peritoneal primary, and fallopian tub…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 2]
The document reports a Phase 2 trial evaluating ZD4054 (Zibotentan) or placebo plus chemotherapy in patients with advanced ovarian cancer. T…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer [Phase 1, Phase 2]
This trial update reports the completion of a Phase 1/2 study evaluating liposomal doxorubicin with carboplatin in gynecologic cancers, incl…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating Telcyta (TLK286) in combination with carboplatin versus Doxil in platinum-refractory or resistant ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer Patients [NA]
Completed clinical trial validating a laparoscopic score to predict the chance of achieving optimal cytoreduction in patients with advanced …
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the combination of liposomal doxorubicin (Doxil) and bortezomib in patients with refractory hematol…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 chemotherapy trial for recurrent, metastatic, or unresectable ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Chemotherapy in Treating Patients With Advanced Sarcoma [Phase 2]
This clinical trial update describes a Phase 2 chemotherapy study for patients with advanced sarcoma, with ovarian cancer listed as an addit…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer [EARLY_Phase 1]
This early-phase 1 trial evaluated tumor necrosis factor in patients undergoing surgery for various primary or metastatic cancers, and the s…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating intraperitoneal heated chemotherapy (IPHC) in platinum-sensitive recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission [Phase 2]
This is a Phase 2 trial of vismodegib as maintenance therapy in ovarian cancer patients in second or third complete remission. Results were …
-
CLINICAL_TRIALS research · 2012-04-25Clinical Trial Update: Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) [Phase 1, Phase 2]
This entry describes a Phase 1/2 clinical trial of an NY-ESO-1–based therapeutic vaccine with the MPLA adjuvant, evaluated in melanoma, ovar…
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers [Phase 2]
A Phase 2 trial evaluating weekly docetaxel (Taxotere) in combination with topotecan for recurrent gynecologic cancers has completed.
-
CLINICAL_TRIALS withdrawal · 2012-04-19Clinical Trial Update: Cost Utility Analysis in Recurrent Ovarian Cancer
A cost-utility analysis clinical trial in recurrent ovarian cancer sponsored by MD Anderson Cancer Center has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update on EPO906 therapy for advanced ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS research · 2012-04-11Clinical Trial Update: A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer [Phase 1]
Phase 1 study evaluating the combination of temsirolimus (Torisel) and pegylated liposomal doxorubicin (Doxil/Caelyx) in advanced or recurre…
-
CLINICAL_TRIALS research · 2012-04-04Clinical Trial Update: A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
Phase II clinical trial update evaluating carboplatin with either paclitaxel or gemcitabine in platinum-sensitive, recurrent ovarian, fallop…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin [Phase 2]
Phase 2 trial evaluated the combination of lapatinib and topotecan in patients with ovarian cancer or primary peritoneal cancer that did not…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: 11C Topotecan PET Imaging [EARLY_Phase 1]
A EARLY Phase 1 trial of 11C-labeled topotecan for PET imaging in lung and ovarian cancers was terminated.
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas [Phase 1]
Phase 1 trial evaluating carboxyamidotriazole in combination with paclitaxel for advanced solid tumors and refractory lymphomas has complete…